市场调查报告书
商品编码
1468526
2024-2032 年透析市场报告(按类型(血液透析、腹膜透析)、产品和服务(服务、设备、消耗品、透析药物)、最终用户(中心透析、家庭透析)和地区)Dialysis Market Report by Type (Hemodialysis, Peritoneal Dialysis), Product and Services (Services, Equipment, Consumables, Dialysis Drugs), End User (In-center Dialysis, Home Dialysis), and Region 2024-2032 |
2023年,IMARC Group透析市场规模达1,158亿美元。透析治疗报销政策的不断增加、需要术后透析的肾臟移植患者数量的增加以及对肾臟疾病早期诊断和干预的日益关注是推动市场的一些因素。
对于肾臟无法自然发挥功能的人来说,透析是一种重要的肾臟替代疗法。这种医疗程序在消除患者血液中的毒素、多余的水、盐和溶质方面发挥着至关重要的作用,有效地恢復了更健康的平衡。透析的主要目的是净化血液并恢復体内适当的电解质水平。此疗法有两种主要形式:血液透析和腹膜透析。血液透析涉及血液的外部净化,这是一个发生在体外的过程。这项技术可以有效净化血液中的杂质,帮助患者恢復稳定。另一方面,腹膜透析依靠腹膜(腹部内壁)来净化血液。透过利用腹膜作为透析介质,该方法提供了一种内部血液净化方法。血液透析和腹膜透析都有助于治疗各种与肾臟相关的疾病。这些治疗通常用于解决急性肾损伤、治疗慢性肾臟疾病、支持肾臟移植手术,或在移植不可行时作为永久解决方案。透析的重要性怎么强调都不为过,因为它可以显着提高患有肾功能障碍的人的生活品质。透过精心实施和医疗技术的不断进步,透析继续成为需要肾臟支持的患者的生命线。
全球市场的主要驱动力是慢性肾臟病盛行率的不断上升。与此一致的是,容易出现肾臟相关问题的老化人口不断增加,对市场做出了重大贡献。此外,人们对肾臟健康和可用治疗方案的认识不断增强,正在对市场产生积极影响。除此之外,科技的快速进步带来了更有效率的透析程序,为市场提供了许多机会。此外,创新透析技术研发的大量投资正在刺激市场。此外,糖尿病(肾臟疾病的主要原因)的发生率较高,也推动了对透析的需求。此外,发展中地区医疗基础设施的扩张也推动了市场的发展。对居家透析解决方案不断增长的需求正在增强市场。
生活方式的改变导致肾臟併发症
生活方式改变的不断升级趋势正在刺激市场。现代生活方式以不良饮食习惯、久坐和高压力为特征,导致肾臟併发症增加。富含加工食品、高盐含量和水分不足的不健康饮食可能导致高血压和糖尿病等慢性疾病,这是肾臟疾病的主要原因。生活方式因素与肾臟併发症之间的相关性促使慢性肾臟疾病的盛行率上升。肾臟相关问题的增加随后增加了对透析治疗的需求,因为受影响的个体需要肾臟替代疗法来维持他们的生活品质。不断扩大的患者群体需要扩大透析服务,进一步推动透析市场的成长。因此,医疗保健提供者、医疗设备製造商和研究人员有动力开发创新的解决方案和策略来满足这一不断增长的需求并提供有效的透析干预措施。
扩大私人透析诊所和中心
私人透析诊所和中心的扩张正在提振市场。这些私人设施具有几个关键优势,有助于扩大市场。私人诊所通常根据个别患者的独特需求提供专门和个人化的护理。这种程度的客製化提高了患者满意度和治疗效果,吸引了更多的客户并刺激了市场需求。此外,私人透析中心往往提供更灵活的安排选项,以适应患者的喜好和常规。这种便利因素吸引了寻求适合其忙碌生活方式的治疗方法的人。此外,私人诊所的设立也促进了市场的良性竞争。这项竞赛鼓励治疗方法、技术采用和患者服务方面的创新,最终提高整个行业的护理品质。此外,私人设施通常配备了最新的透析机、技术和熟练的医务人员,确保高效和有效的治疗。这种高标准的护理有助于在患者和转诊医生之间建立信任,进一步推动患者转诊和市场成长。私人透析诊所为寻求透析服务的患者提供替代选择,有助于减轻公共医疗保健系统的负担。这一点在公共资源有限的地区尤其重要,因为私立中心可以减轻医疗基础设施的压力。
连续门诊腹膜透析 (CAPD) 和自动腹膜透析 (APD) 的需求不断增长
连续流动腹膜透析(CAPD)和自动腹膜透析(APD)的需求不断增长正在推动市场成长。这些先进的腹膜透析技术具有许多优势,使其越来越受欢迎。 CAPD和APD为患者提供比传统中心血液透析更灵活、更方便的治疗选择。 CAPD 允许患者全天手动更换透析液,从而在接受治疗的同时提供更大的自由度和继续日常活动的能力。 APD 透过利用机器在夜间自动进行透析液交换,使患者在睡眠时接受治疗,进一步提高了便利性。对 CAPD 和 APD 的需求源于其稳定、持续的毒素清除能力,从而使血液化学成分更加稳定并改善整体健康状况。这些技术也最大限度地减少了频繁前往透析中心的需要,减少了对患者日常生活的干扰。此外,CAPD 和 APD 非常适合家庭护理,符合个人化医疗保健和远端监控日益增长的趋势。患者可以接受在家中执行这些手术的培训,让他们有一种对治疗的授权和控制感。随着患者和医疗保健提供者越来越认识到 CAPD 和 APD 的好处,对这些技术的需求预计将会上升。这反过来又透过鼓励腹膜透析技术的进一步研究和创新以及为选择这些方法的患者扩大培训计划和支援服务来推动市场成长。
The global dialysis market size reached US$ 115.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 170.4 Billion by 2032, exhibiting a growth rate (CAGR) of 4.3% during 2024-2032. The increasing availability of reimbursement policies for dialysis treatments, the rising number of kidney transplant patients requiring post-operative dialysis, and the growing focus on early diagnosis and intervention for kidney diseases are some of the factors propelling the market.
Dialysis is a crucial renal replacement therapy for individuals whose kidneys cannot function naturally. This medical procedure plays a vital role in eliminating toxins, excess water, salts, and solutes from the patient's bloodstream, effectively restoring a healthier balance. The primary objective of dialysis is to purify the blood and restore proper electrolyte levels within the body. This therapy comes in two main forms: hemodialysis and peritoneal dialysis. Hemodialysis involves the external purification of blood, a process that occurs outside the body. This technique effectively cleanses the blood of impurities, helping patients regain stability. On the other hand, peritoneal dialysis relies on the peritoneum, a lining within the abdomen, to purify the blood. By utilizing the peritoneum as a dialysis medium, this method offers an internal approach to blood cleansing. Both hemodialysis and peritoneal dialysis are instrumental in treating various kidney-related conditions. These treatments are commonly employed for addressing acute renal injuries, managing chronic kidney diseases, supporting kidney transplant procedures, or serving as a permanent solution when transplantation is not a viable option. The significance of dialysis cannot be overstated, as it significantly enhances the quality of life for individuals grappling with kidney dysfunctions. Through careful implementation and ongoing advancements in medical technology, dialysis continues to serve as a lifeline for patients needing renal support.
The global market is majorly driven by the increasing prevalence of chronic kidney diseases. In line with this, the rising aging population prone to kidney-related issues is significantly contributing to the market. Furthermore, the growing awareness about renal health and available treatment options is positively influencing the market. Apart from this, the rapid technological advancements leading to more efficient dialysis procedures are offering numerous opportunities for the market. Moreover, the heavy investments in research and development of innovative dialysis techniques are catalyzing the market. Besides, the higher incidence of diabetes, a major contributor to kidney diseases, is propelling the demand for dialysis. Additionally, the expansion of healthcare infrastructure in developing regions is providing a boost to the market. The escalating demand for home-based dialysis solutions is strengthening the market.
Increasing lifestyle changes lead to kidney complications
The escalating trend of lifestyle changes is stimulating the market. Modern lifestyles characterized by poor dietary habits, sedentary routines, and high-stress levels contribute to a rise in kidney complications. Unhealthy diets rich in processed foods, high salt content, and inadequate hydration can lead to chronic conditions such as hypertension and diabetes, which are major causes of kidney diseases. The correlation between lifestyle factors and kidney complications has prompted an upswing in the prevalence of chronic kidney diseases. This rise in kidney-related issues has subsequently increased the demand for dialysis treatments, as affected individuals require renal replacement therapy to maintain their quality of life. The expanding patient pool necessitates the expansion of dialysis services, further driving the growth of the dialysis market. Consequently, healthcare providers, medical device manufacturers, and researchers are motivated to develop innovative solutions and strategies to address this growing demand and offer effective dialysis interventions.
Expansion of private dialysis clinics and centers
The expansion of private dialysis clinics and centers is bolstering the market. These private facilities offer several key advantages that contribute to their impact on market expansion. Private clinics often provide specialized and personalized care tailored to the unique needs of individual patients. This level of customization enhances patient satisfaction and outcomes, attracting a larger clientele and boosting market demand. Furthermore, private dialysis centers tend to offer more flexible scheduling options, accommodating patients' preferences and routines. This convenience factor attracts individuals seeking treatments that align with their busy lifestyles. Moreover, the establishment of private clinics fosters healthy competition within the market. This competition encourages innovation in treatment methodologies, technology adoption, and patient services, ultimately leading to improved quality of care across the industry. Additionally, private facilities are often well-equipped with the latest dialysis machines, technologies, and skilled medical personnel, ensuring efficient and effective treatments. This high standard of care helps build trust among patients and referring physicians, further driving patient referrals and market growth. Private dialysis clinics contribute to reducing the burden on public healthcare systems by providing alternative options for patients seeking dialysis services. This aspect is particularly crucial in regions with limited public resources, as private centers can alleviate strain on the healthcare infrastructure.
Rising demand for continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)
The escalating demand for Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD) is fueling the market growth. These advanced peritoneal dialysis techniques offer numerous advantages that contribute to their increasing popularity. CAPD and APD provide patients with more flexible and convenient treatment options than traditional in-center hemodialysis. CAPD allows patients to perform manual exchanges of dialysate fluid throughout the day, offering greater freedom and the ability to continue daily activities while undergoing treatment. APD takes convenience a step further by utilizing a machine to automate dialysate exchanges at night, allowing patients to receive treatment while they sleep. The demand for CAPD and APD is driven by their ability to provide steady and continuous toxin removal, leading to more stable blood chemistry and improved overall health. These techniques also minimize the need for frequent visits to a dialysis center, reducing the disruption to patients' daily lives. Furthermore, CAPD and APD are well-suited for home-based care, aligning with the growing trend towards personalized healthcare and remote monitoring. Patients can receive training to perform these procedures at home, giving them a sense of empowerment and control over their treatment. As patients and healthcare providers increasingly recognize the benefits of CAPD and APD, the demand for these techniques is expected to rise. This, in turn, drives market growth by encouraging further research and innovation in peritoneal dialysis technology, as well as the expansion of training programs and support services for patients opting for these methods.
IMARC Group provides an analysis of the key trends in each segment of the global dialysis market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, product and services, and end user.
Hemodialysis
Conventional Hemodialysis
Short Daily Hemodialysis
Nocturnal Hemodialysis
Peritoneal Dialysis
Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)
Hemodialysis dominates the market
The report has provided a detailed breakup and analysis of the market based on the type. This includes hemodialysis (conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis) and peritoneal dialysis (continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)). According to the report, hemodialysis represented the largest segment.
Hemodialysis, a prominent renal replacement therapy, exerts substantial influence due to its widespread adoption and several associated factors. Its efficacy in rapidly removing toxins, excess fluids, and waste products from the bloodstream addresses critical medical needs in patients with kidney dysfunction. As a result, its demand is driven by the growing prevalence of chronic kidney diseases, kidney failures, and related conditions. The continuous advancement of hemodialysis technology has improved treatment outcomes and enhanced patient experiences.
Innovations such as high-efficiency dialyzers, vascular access techniques, and online monitoring systems have made hemodialysis more effective, comfortable, and accessible. Moreover, establishing specialized hemodialysis centers and integrating telehealth solutions has widened the reach of this treatment, making it accessible to more patients, including those in remote areas. These factors combined contribute to the segment's pivotal role in driving overall market growth as the demand for efficient renal replacement therapies rises.
Services
Equipment
Dialysis Machines
Water Treatment Systems
Others
Consumables
Dialyzers
Catheters
Others
Dialysis Drugs
Services dominates the market
The report has provided a detailed breakup and analysis of the market based on the product and services. This includes services, equipment (dialysis machines, water treatment systems, and others), consumables (dialyzers, catheters, and others), and dialysis drugs. According to the report, services represented the largest segment.
The services segment is vital in driving market growth within the dialysis industry. This segment encompasses a range of essential offerings that directly impact patient care, treatment accessibility, and overall industry expansion. Medical service providers, including healthcare professionals and specialized dialysis clinics, contribute significantly to the growth of this segment. These services encompass various aspects of patient care, from initial diagnosis and treatment planning to ongoing monitoring and support. The availability of high-quality medical services is crucial in attracting patients to seek timely interventions for kidney-related issues.
Furthermore, the services segment includes patient education and awareness initiatives. These programs empower patients with knowledge about kidney health, available treatment options, and self-care practices. By raising awareness and promoting early intervention, these educational efforts contribute to higher demand for dialysis services. The expansion of telehealth services is also a driving factor. Remote monitoring and consultation services enable patients to access medical guidance without frequent in-person visits, making dialysis care more convenient and efficient.
In-center Dialysis
Home Dialysis
In-center dialysis dominates the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes in-center dialysis and home dialysis. According to the report, in-center dialysis represented the largest segment.
The in-center dialysis segment is a key driver of market growth within the dialysis industry. This segment caters to a substantial portion of the patient population, contributing significantly to the demand for dialysis services. In-center dialysis refers to treatments conducted within specialized dialysis centers or clinics under the supervision of trained medical professionals. This setting offers various advantages, including access to advanced medical equipment, close monitoring by healthcare staff, and the opportunity for patients to interact with peers facing similar health challenges.
The convenience and comprehensive care provided by in-center dialysis centers attract patients who require regular and closely supervised treatments. This includes individuals with advanced kidney diseases, complex medical histories, or those who benefit from personalized care plans. Moreover, in-center dialysis centers often house cutting-edge technology and skilled healthcare teams, ensuring high-quality treatment delivery. Patients appreciate the structured environment, professional support, and regular check-ins that in-center dialysis provides.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
With its well-established healthcare infrastructure, North America is at the forefront of adopting and implementing innovative dialysis technologies and treatment methodologies. This region's focus on research and development fosters continuous advancements in dialysis machines, equipment, and treatment protocols, enhancing the overall quality of patient care. The increasing prevalence of chronic kidney diseases, often associated with lifestyle factors such as obesity and diabetes, drives the demand for dialysis services in North America. A significant aging population also contributes to the rising need for renal replacement therapies.
Government initiatives, reimbursement policies, and awareness campaigns further promote early diagnosis and intervention for kidney-related issues, boosting the utilization of dialysis treatments. Additionally, the concentration of leading dialysis companies and medical research institutions in North America fuels the development and dissemination of state-of-the-art dialysis solutions.
Top companies are playing a crucial role in fostering the growth of the dialysis market through strategic initiatives and innovations. Armed with their extensive resources and expertise, these companies are driving market expansion in several ways. They invest heavily in research and development, leading to the creation of advanced dialysis technologies and treatment methods. This continuous innovation improves dialysis's efficacy, efficiency, and patient experience, enticing more individuals to opt for these treatments. Moreover, these companies collaborate with healthcare providers and institutions, ensuring widespread access to their products and services. Such partnerships facilitate the integration of cutting-edge dialysis solutions into existing healthcare ecosystems, thus expanding the market reach. Additionally, top companies often engage in awareness campaigns to educate the medical community and the general public about kidney health and available treatment options. This educational effort drives early diagnosis and intervention, increasing the demand for dialysis services. Besides, their global presence and distribution networks enable them to bring advanced dialysis solutions to regions with limited access to healthcare infrastructure. This expansion into underserved areas contributes to market growth by catering to a wider patient demographic.
The report has provided a comprehensive analysis of the competitive landscape in the dialysis market. Detailed profiles of all major companies have also been provided.
Asahi Kasei Corporation
B. Braun Melsungen AG
Baxter International Inc.
Becton Dickinson and Company
DaVita Inc.
Fresenius Medical Care AG & Co. KGaA
JMS Co. Ltd.
Medtronic plc
Nikkiso Co. Ltd.
NIPRO Corporation
Satellite Healthcare Inc.
Toray Industries Inc.
Toray Industries Inc. developed Japan's first polymethyl methacrylate (PMMA) hollow fiber membrane-based hemodiafiltration device in November 2021, addressing the need for alternative materials and improved performance in artificial kidneys. The PMMA hemodiafiltration device offers excellent biocompatibility and uremic toxin removal, thereby contributing to better medical care for patients with renal failure.
In 2021, Becton Dickinson and Company received FDA clearance for the Pristine Long-Term Hemodialysis Catheter, which features a unique side-hole free symmetric Y-Tip design to address complications associated with traditional catheters.
Satellite Healthcare Inc. has introduced a new care model designed for individuals recently diagnosed with kidney disease requiring dialysis, named Kidney Care Connection (KCC) in 2022. KCC offers spacious patient rooms, a demonstration kitchen for learning about healthy meals, and the option to transition to home dialysis after a few weeks.